InsiderTrades

Form 4 for TNDM TANDEM DIABETES CARE INC

Accepted 2022-03-02 00:00:00 ET · period of report 2022-02-28 · accession 0001438133-22-000029 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-03-02 2022-02-28 TNDM Vosseller Leigh EVP, CFO M - OptEx $0.00 +407 6,756 +6% $0
D 2022-03-02 2022-02-28 TNDM Vosseller Leigh EVP, CFO F - Tax $112.43 -138 6,618 -2% -$15.5K
D 2022-03-02 2022-02-28 TNDM Vosseller Leigh EVP, CFO M - OptEx $0.00 +407 3,658 +13% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-28 M A 407 $0.00 6,756 D — —
2 Common Common Stock 2022-02-28 F D 138 $112.43 6,618 D — —
3 Derivative Restricted Stock Unit 2022-02-28 M A 407 $0.00 3,658 D — · — to — 407 Common Stock (F3) Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). (F4) Each RSU represents a contingent right to receive one share of common stock of the Company. (F5) RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.